Dafinchi
Integer Q1 2026 Sales Surpass Expectations with Organic Growth
Integer's Q1 2026 results indicate steady revenue with a slight increase in reported sales and a more substantial rise in organic sales, reflecting strong core growth.
Read post
Detailed company information
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q1Released: Apr 30, 2026
Earnings Transcript for 2025 - Q4Released: Feb 19, 2026
Earnings Transcript for 2025 - Q3Released: Oct 23, 2025
Earnings Transcript for 2025 - Q2Released: Jul 25, 2025
Earnings Transcript for 2025 - Q1Released: Apr 24, 2025
Earnings Transcript for 2024 - Q4Released: Feb 20, 2025
Earnings Transcript for 2024 - Q3Released: Oct 24, 2024
Earnings Transcript for 2024 - Q2Released: Jul 25, 2024
Earnings Transcript for 2024 - Q1Released: Apr 25, 2024
Earnings Transcript for 2023 - Q4Released: Feb 15, 2024
Earnings Transcript for 2023 - Q3Released: Oct 26, 2023
Earnings Transcript for 2023 - Q2Released: Jul 27, 2023
Earnings Transcript for 2023 - Q1Released: May 01, 2023
Earnings Transcript for 2022 - Q4Released: Feb 18, 2023
Earnings Transcript for 2022 - Q3Released: Oct 29, 2022
Earnings Transcript for 2022 - Q2Released: Jul 31, 2022
Earnings Transcript for 2022 - Q1Released: May 01, 2022
Earnings Transcript for 2021 - Q4Released: Feb 17, 2022
Earnings Transcript for 2021 - Q3Released: Oct 29, 2021
Earnings Transcript for 2021 - Q2Released: Jul 31, 2021
Earnings Transcript for 2021 - Q1Released: May 01, 2021
Earnings Transcript for 2020 - Q4Released: Feb 18, 2021
Earnings Transcript for 2020 - Q3Released: Oct 29, 2020
Earnings Transcript for 2020 - Q2Released: Aug 02, 2020
Integer's Q1 2026 results indicate steady revenue with a slight increase in reported sales and a more substantial rise in organic sales, reflecting strong core growth.
Read post